Pridopidine

N/A

Report date: 2026/04/25 20:00:23
NME

Base Information

Drug NamePridopidine
Drug Alias Namepridopidine普利多匹定pridopidinapridopidinumHuntexil +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsSigma opioid receptor agonists
TargetsSigma opioid receptorDopamine D2 receptor
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[17
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A

Develop Information

Active IndicationsAmyotrophic Lateral SclerosisHuntington Disease
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG